Search alternatives:
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
5 step » _ step (Expand Search), a step (Expand Search), 2 step (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
5 step » _ step (Expand Search), a step (Expand Search), 2 step (Expand Search)
-
7041
Evidence for selection on SARS-CoV-2 RNA translation revealed by the evolutionary dynamics of mutations in UTRs and CDSs
Published 2022“…We defined adaptive and deleterious mutations according to the rise and fall of their frequencies along time. For 5ʹUTR and synonymous mutations in SARS-CoV-2, the selection on TE is evident near start codons. …”
-
7042
Data Sheet 7_Phosphodiesterase 7: a potential novel therapeutic target in ovarian cancer.pdf
Published 2025“…</p>Results and discussion<p>MTT assays revealed that while BRL 50481 reduced metabolic cellular viability (MCV) in A2780 (IC50 = 200 μM), its combination with PTX decreased MCV in both lines, reducing PTX IC50 by 103- and 625-fold in A2780 and OVCAR3, respectively. …”
-
7043
Data Sheet 6_Phosphodiesterase 7: a potential novel therapeutic target in ovarian cancer.pdf
Published 2025“…</p>Results and discussion<p>MTT assays revealed that while BRL 50481 reduced metabolic cellular viability (MCV) in A2780 (IC50 = 200 μM), its combination with PTX decreased MCV in both lines, reducing PTX IC50 by 103- and 625-fold in A2780 and OVCAR3, respectively. …”
-
7044
Data Sheet 1_Phosphodiesterase 7: a potential novel therapeutic target in ovarian cancer.pdf
Published 2025“…</p>Results and discussion<p>MTT assays revealed that while BRL 50481 reduced metabolic cellular viability (MCV) in A2780 (IC50 = 200 μM), its combination with PTX decreased MCV in both lines, reducing PTX IC50 by 103- and 625-fold in A2780 and OVCAR3, respectively. …”
-
7045
Data Sheet 3_Phosphodiesterase 7: a potential novel therapeutic target in ovarian cancer.pdf
Published 2025“…</p>Results and discussion<p>MTT assays revealed that while BRL 50481 reduced metabolic cellular viability (MCV) in A2780 (IC50 = 200 μM), its combination with PTX decreased MCV in both lines, reducing PTX IC50 by 103- and 625-fold in A2780 and OVCAR3, respectively. …”
-
7046
Data Sheet 8_Phosphodiesterase 7: a potential novel therapeutic target in ovarian cancer.pdf
Published 2025“…</p>Results and discussion<p>MTT assays revealed that while BRL 50481 reduced metabolic cellular viability (MCV) in A2780 (IC50 = 200 μM), its combination with PTX decreased MCV in both lines, reducing PTX IC50 by 103- and 625-fold in A2780 and OVCAR3, respectively. …”
-
7047
Data Sheet 4_Phosphodiesterase 7: a potential novel therapeutic target in ovarian cancer.pdf
Published 2025“…</p>Results and discussion<p>MTT assays revealed that while BRL 50481 reduced metabolic cellular viability (MCV) in A2780 (IC50 = 200 μM), its combination with PTX decreased MCV in both lines, reducing PTX IC50 by 103- and 625-fold in A2780 and OVCAR3, respectively. …”
-
7048
Data Sheet 5_Phosphodiesterase 7: a potential novel therapeutic target in ovarian cancer.pdf
Published 2025“…</p>Results and discussion<p>MTT assays revealed that while BRL 50481 reduced metabolic cellular viability (MCV) in A2780 (IC50 = 200 μM), its combination with PTX decreased MCV in both lines, reducing PTX IC50 by 103- and 625-fold in A2780 and OVCAR3, respectively. …”
-
7049
Data Sheet 2_Phosphodiesterase 7: a potential novel therapeutic target in ovarian cancer.pdf
Published 2025“…</p>Results and discussion<p>MTT assays revealed that while BRL 50481 reduced metabolic cellular viability (MCV) in A2780 (IC50 = 200 μM), its combination with PTX decreased MCV in both lines, reducing PTX IC50 by 103- and 625-fold in A2780 and OVCAR3, respectively. …”
-
7050
-
7051
-
7052
-
7053
-
7054
Deterministic transitions have a different signature than stochastic ones.
Published 2024“…Inset, middle: histogram of average activity after 200 presentation time steps under a given rule. Black bars: comparison of activity under rules A and B in SpikeSuM without context. …”
-
7055
-
7056
The Deoxyhypusine Synthase Mutant <i>dys1-1</i> Reveals the Association of eIF5A and Asc1 with Cell Wall Integrity
Published 2013“…<div><p>The putative eukaryotic translation initiation factor 5A (eIF5A) is a highly conserved protein among archaea and eukaryotes that has recently been implicated in the elongation step of translation. eIF5A undergoes an essential and conserved posttranslational modification at a specific lysine to generate the residue hypusine. …”
-
7057
-
7058
Lethal Mutagenesis of Hepatitis C Virus Induced by Favipiravir
Published 2016“…Infectivity decreased significantly in the presence of concentrations of T-705 which are 2- to 8-fold lower than its cytotoxic concentration 50 (CC<sub>50</sub>). …”
-
7059
Spatial relationship between <i>Taenia solium</i> tapeworm carriers and necropsy cyst burden in pigs
Published 2017“…The prevalence of pig infection was greatest within 50 meters of a tapeworm carrier and decreased monotonically as distance increased. …”
-
7060
Inhibitory activity of pentacyano(isoniazid)ferrate(II), IQG-607, against promastigotes and amastigotes forms of <i>Leishmania braziliensis</i>
Published 2017“…The pentacyano(isoniazid)ferrate(II) compound, named IQG-607, inhibits the enzyme 2-trans-enoyl-ACP(CoA) reductase from <i>M</i>. <i>tuberculosis</i>, a key component in the FASII system. …”